No connection

Search Results

GJS

BEARISH
$23.55 Live
STRATS Trust for Goldman Sachs Group Securities, Series 2006-2 · NYSE
$22.26 52W Range $24.68

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 28, 2026
Market cap
N/A
P/E
N/A
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
The deterministic health profile for GJS is critically weak, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental deterioration. While the asset has shown positive long-term price appreciation (+42.3% over 5 years), the current technical trend is 0/100 (Bearish) and there is a complete absence of traditional valuation, profitability, and growth metrics. As a trust vehicle rather than an operating company, it lacks the transparency and cash-flow generation required for a bullish rating. The combination of a failing health score and bearish technicals outweighs historical price gains.

Key Strengths

Positive 5-year price performance (+42.3%)
Positive 1-year price performance (+10.8%)
Relatively low price volatility (52-week range $22.26 - $24.68)
Consistent long-term upward trajectory
Association with Goldman Sachs Group Securities

Key Risks

Critically low Piotroski F-Score (1/9) indicating poor financial health
Complete lack of fundamental valuation data (P/E, P/B, EV/EBITDA)
Bearish technical trend (0/100)
Zero dividend strength and no income generation
Lack of analyst coverage and transparency

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
23
Weak
Value
0
Future
30
Past
75
Health
11
Dividend
0
AI Verdict
High Risk / Speculative
Key drivers: Piotroski F-Score failure, Bearish technical trend, Absence of fundamental data
Confidence
90%
Value
0/100

Ref P/E, PEG, Graham Number

Positives
No standout positives identified.
Watchpoints
  • No P/E, PEG, or Graham Number available for calculation
Future
30/100

Ref Growth rates

Positives
  • Historical price growth
Watchpoints
  • Technical trend is 0/100
  • No growth metrics provided
Past
75/100

Ref Historical trends

Positives
  • 5Y Change +42.3%
  • 3Y Change +31.4%
  • 1Y Change +10.8%
Watchpoints
No urgent risks highlighted.
Health
11/100

Ref Altman Z-Score, Piotroski F-Score

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score of 1/9 is extremely weak
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • Dividend strength 0/100
  • No yield reported

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$23.55

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for GJS and closest competitors.

Updated 2026-04-27
GJS
STRATS Trust for Goldman Sachs Group Securities, Series 2006-2
Primary
5Y
+42.3%
3Y
+31.4%
1Y
+10.8%
6M
+5.0%
1M
+0.2%
1W
+1.3%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
N/A
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A

SEC Filings

Recent regulatory filings from the SEC EDGAR database

10-K
ANNUAL REPORT
2026-03-30

GJS filed its annual 10-K report on March 30, 2026, covering its business operations, financial condition, and risk factors. Specific financial highlights and risk details were not provided in the available excerpts.

10-K
ANNUAL REPORT
2025-03-31

GJS filed its 10-K annual report on March 31, 2025, which includes sections on business operations, financial condition, and risk factors. No specific financial highlights or detailed risk disclosures were provided in the available excerpts.

Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning GJS from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile